Treatment with a dual amylin and calcitonin receptor agonist improves metabolic health in an old, obese, and ovariectomized rat model. [PDF]
Menopause, 2021 Katri A +4 more
europepmc +1 more source
Amylin Revisited: A 5-Year Perspective on Its Emerging Role in the Treatment of Diabesity. [PDF]
J Obes Metab SyndrChung CW, Kim J.
europepmc +1 more source
Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies. [PDF]
Front Endocrinol (Lausanne)Alhazmi A, le Roux CW.
europepmc +1 more source
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass? [PDF]
Rev Endocr Metab DisordRyan DH.
europepmc +1 more source
The roles of hepatokine and osteokine in liver-bone crosstalk: Advance in basic and clinical aspects. [PDF]
Front Endocrinol (Lausanne), 2023 Li Z +8 more
europepmc +1 more source
Structural basis of modified ligand selectivity from N-terminal PAC1R alternative splicing. [PDF]
Proc Natl Acad Sci U S ALu JJ +13 more
europepmc +1 more source
Linking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective. [PDF]
Biosci Rep, 2022 Hassan S, White K, Terry C.
europepmc +1 more source
Approved and Emerging Hormone-Based Anti-Obesity Medications: A Review Article. [PDF]
Indian J Endocrinol MetabSidrak WR, Kalra S, Kalhan A.
europepmc +1 more source
PET Image Reconstruction Using Deep Diffusion Image Prior. [PDF]
IEEE Trans Med ImagingHashimoto F, Gong K.
europepmc +1 more source
In vivo functional profiling and structural characterization of the human <i>GLP1R</i> A316T variant. [PDF]
Sci AdvEl Eid L +20 more
europepmc +1 more source